A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors

被引:42
作者
Kearney, MT
Nolan, J
Lee, AJ
Brooksby, PW
Prescott, R
Shah, AM
Zaman, AG
Eckberg, DL
Lindsay, HS
Batin, PD
Andrews, R
Fox, KAA
机构
[1] Kings Coll London, GKT Sch Med, Dept Cardiol, London SE5 9PJ, England
[2] Univ Edinburgh, Med Stat Unit, Edinburgh, Midlothian, Scotland
[3] Ponterfact Hosp, Ponterfact, England
[4] Freeman Hosp Newcastle, Newcastle Upon Tyne, Tyne & Wear, England
[5] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23284 USA
[6] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England
[7] Lincoln Cty Hosp, Lincoln LN2 5QY, Lincs, England
[8] Univ Edinburgh, Dept Cardiol, Edinburgh, Midlothian, Scotland
关键词
heart failure; prognosis; mortality;
D O I
10.1016/S1388-9842(03)00053-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mortality in patients with mild to moderate chronic heart failure remains high. At present there is no easy way of identifying patients within this population at increased risk of death in the medium to long term. Aims: To develop a prognostic index to identify outpatients with mild to moderate chronic heart failure at increased risk of death. Methods and results: Five hundred and fifty-three outpatients mean (S.D.) age 63(+/-10) years with symptoms of chronic heart failure (mean New York Heart Association functional class, 2.3( +/-0.5)), were recruited between December 1993 and April 1995. By April 2000, 201 patients had died. Using data from non-invasive measurements of cardiac size, electrical and autonomic function, renal function and plasma biochemistry we identified eight independent predictors of mortality (all P<0.01). To develop a prognostic index, predictors were dichotomised by group median and awarded 0 or 1 point accordingly. Serum sodium less than or equal to 140 mmol/l (1 point), creatinine greater than or equal to 111 mumol/l (1 point), cardiothoracic ratio greater than or equal to 0.52 (1 point), SDNN less than or equal to 112 ms (1 point), maximum corrected QT interval greater than or equal to 487 ms (1 point), QRS dispersion greater than or equal to 42.7 ms (1 point), the presence of non-sustained ventricular tachycardia (1 point) and voltage criteria for left ventricular hypertrophy on 12-lead ECG (1 point). We calculated risk scores for patients by adding the points of each independent risk factor. In the low-risk group (0-3 points) mortality at 5 years was 20% and in the high-risk group (4-8 points) 53%. The area under the receiver-operator characteristic curve using dichotomised variables was 0.74 and for continuous model 0.78. Conclusions: Our prognostic index which uses eight non-invasive measurements and a straightforward additive points system, has good discrimination and stratifies outpatients with chronic heart failure into high and low risk. This index may be useful in clinical care and risk stratification. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:489 / 497
页数:9
相关论文
共 37 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]   Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure - Characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction [J].
Adamson, PB ;
Vanoli, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1741-1748
[3]  
[Anonymous], 1988, JAMA, V259, P539
[4]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[5]   QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide [J].
Brendorp, B ;
Elming, H ;
Jun, L ;
Kober, L ;
Malik, M ;
Jensen, GB ;
Torp-Pedersen, C .
CIRCULATION, 2001, 103 (10) :1422-1427
[6]   The relationship between QT intervals and mortality in ambulant patients with chronic heart failure - The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) [J].
Brooksby, P ;
Batin, PD ;
Nolan, J ;
Lindsay, SJ ;
Andrews, R ;
Mullen, M ;
Baig, W ;
Flapan, AD ;
Prescott, RJ ;
Neilson, JMM ;
Cowley, AJ ;
Fox, KAA .
EUROPEAN HEART JOURNAL, 1999, 20 (18) :1335-1341
[7]  
Camm AJ, 1996, CIRCULATION, V93, P1043
[8]  
CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756
[9]   Attitude and self-reported practice regarding prognostication in a national sample of internists [J].
Christakis, NA ;
Iwashyna, TJ .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (21) :2389-2395
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187